Skip to main content
PLOS Global Public Health logoLink to PLOS Global Public Health
. 2026 Jul 27;6(7):e0006808. doi: 10.1371/journal.pgph.0006808

Geospatial disparities in post-pandemic SARS-CoV-2 vaccination: Evidence from Chile beyond the national success

Muriel Ramírez-Santana 1,#, Juan Correa 2,3,#, Paola Rubilar 4, Mauricio Apablaza 5, Luis Canales 6, Loreto Nuñez-Franz 7,*
Editor: Abram L Wagner8
PMCID: PMC13405313  PMID: 42507683

Abstract

While Chile achieved one of the world’s highest and most equitable SARS-CoV-2 vaccination coverages during the pandemic, less is known about the post-pandemic stage. This study examines within-country geospatial disparities in COVID-19 vaccination uptake and their socio-demographic determinants in two urban areas of Chile. A population-based survey conducted in May 2024 collected individual data on vaccination status and socio-demographic characteristics. These were georeferenced and linked to census information at the household block level. Spatial analyses explored clustering and correlations between the number of vaccine doses and variables such as age structure, educational attainment, overcrowding, and proximity to public health facilities. Moran’s Index was used to assess spatial autocorrelation and bivariate relationships, disaggregated by sex and city. The number of vaccine doses inoculated displayed significant spatial concentration, particularly among women. A positive spatial correlation was found between vaccination and higher education, and a negative correlation with overcrowding in one city. Distance to health facilities was not significantly associated with vaccine uptake. Across both cities, a higher proportion of older adults was associated with higher vaccination rates, with gender-specific patterns observed. Despite Chile’s previously homogeneous vaccination performance, post-pandemic findings reveal emerging socio-spatial disparities. The return of demographic and territorial determinants suggests a shift toward structural influences on vaccine uptake. These results underscore the need for territorially tailored public health strategies to reduce intra-country disparities in immunization access over time.

Introduction

The influence of geographical conditions on the distribution of diseases and health interventions, such as vaccinations, is well known [1–9]. Spatial disparities can shape both disease distribution and access to preventive measures, of which vaccination is one of the most important strategies for controlling infectious diseases [10]Several studies have focused on describing the spatial distribution and geographical determinants related to vaccination coverage and vaccine access worldwide [1–9]. Some factors identified as influencing general vaccination distribution in territories are socioeconomic status [8,11,12], car ownership [3,13], access to health facilities [5,9], health status [14], population density [3,15], ethnic diversity [12,16], educational level [1,5,16], rurality [17], religion [5], employment [18], sex [19], age, and insurance status [12,20].

However, studies on the spatial distribution and territorial determinants of vaccination coverage in the post-pandemic phase of SARS-CoV-2 are scarce [6,12,14,21], especially in Latin America. Understanding how vaccination patterns evolve beyond the emergency phase is crucial for designing new policies to ensure equitable immunization coverage, particularly as public health priorities shift and risk perceptions decline. Specifically, during COVID-19, the epidemiological situation was a key driver of vaccination [21]. Thus, once the pandemic was over, in August 2023 [22], risk perception decreased, and motivation to be vaccinated declined, resulting in lower vaccination coverage.

Chile represents a compelling case study for examining vaccination dynamics in the post-SARS-CoV-2 era. During the first year of the COVID-19 pandemic in Chile, a social disparity was observed in the territorial distribution of immunity (before vaccination), identifying clusters of infection in the most vulnerable neighborhoods [23,24]. Subsequently, with the implementation of vaccination, these geographical disparities of immunity were reduced. Vaccination was uniformly distributed across the territories thanks to a broad, unrestricted access campaign [25].

Following the WHO recommendations [26], since 2023, the Chilean Ministry of Health has decided to include the vaccine against COVID-19 in the national vaccination schedule, focusing on specific population groups who are at higher risk of developing severe disease [27]. Vaccines against SARS-CoV-2 were still necessary for individuals at risk of serious disease in 2024. The elderly and those with chronic conditions remain particularly vulnerable to severe outcomes. Additionally, the emergence of new variants and vaccine escape mechanisms justifies the continuation of vaccination campaigns, in line with the recommendations of Chilean health authorities. However, it has been challenging to maintain sufficient vaccination coverage lately. As the pandemic progressed and the urgency regarding vaccination declined, vaccination coverage has also been deteriorating and may be affected by socio-demographic determinants [28].

In a multidimensional study of the spatial process of COVID-19 vaccination in the United States, Yang argues that the spatial processes underlying vaccination coverage are essentially local [13]. Thus, outreach strategies need to be adjusted to achieve the objective. Helpful information is imperative for tailoring vaccination strategies and public messages [29]

This study aims to identify the geospatial distribution of post-pandemic SARS-CoV-2 vaccination in two Chilean cities and explore the socio-demographic factors influencing vaccine uptake, disaggregated by sex. The underlying hypothesis is that, once the epidemic ended, socio-demographic factors shaped access to vaccination, resulting in a heterogeneous geographical distribution of immunization.

Materials and methods

Study design

This is a population-based cross-sectional study. From 02/05/2024 to 31/05/2024, the recruitment and fieldwork phase of a four-round population-based COVID-19 seroprevalence study was conducted in Talca and the La Serena/Coquimbo conurbation in Chile. The present study and three previous [23,28] were conducted by researchers affiliated with three universities, two of which are located in the cities selected for fieldwork. City selection follows a convenience sampling approach, reflecting the researchers´ institutional locations and their established relationships with local health and community networks.

Participants and setting

The La Serena/Coquimbo conurbation is located 450 kilometers from Santiago (the country’s capital) and Talca, 250 kilometers south of the capital. Serum samples were tested for antibodies against SARS-CoV-2 at a university laboratory in Santiago (Fig 1). Stratified two-stage random sampling by census district was carried out. First, a block random selection, and second, a household selection using systematic skip. Within the household, all members aged 7 years or older were invited to participate, without exclusion. Details of the methodology and participant selection can be found in Nuñez-Franz et al. (2025) [28].

Fig 1. Map of Chile and survey locations.

Fig 1

Source: Designed by the authors. Regional and communal administrative boundaries were sourced from the World Bank Official Boundaries dataset (World Bank, 2025; https://datacatalog.worldbank.org/search/dataset/0038272/world-bank-official-boundaries), licensed under CC BY 4.0 (https://datacatalog.worldbank.org/public-licenses?fragment=cc). Satellite images were sourced from the United States Geological Survey EarthExplorer platform (USGS, 2026: https://earthexplorer.usgs.gov/), which are U.S. Public Domain (https://www.usgs.gov/information-policies-and-instructions/copyrights-and-credits). Attribution is displayed in the lower right corner of each map. No proprietary mapping services were used.

A total of 654 people were enrolled. The sample of participants proved to be representative and evenly distributed in both cities. Spaces without participants in the cities correspond to uninhabited sectors, designated for agricultural or commercial use. These areas were identified using digital mapping from the Chilean Instituto Nacional de Estadísticas, generated for the population and housing census, which digitized only blocks with more than five residents and excluded non-residential areas [30]. This was observed especially in the city center of Talca.

Variables

The dependent variable corresponds to each case’s total number of vaccine doses, while the independent variables are territorial factors. For this, each case was geo-referenced to its census block [31] and subsequently assigned the socio-demographic information of its census tract, such as age, education, overcrowding, and access to health facilities. The proportion of older adults (aged sixty-five and over) was considered for age. The educational level was analyzed as the percentage of the population with a higher level of education (higher technical or university, postgraduate). For overcrowding, the rate of households where 2.5 or more people share a bedroom was used [32,33], and access to healthcare was operationalized as the distance to the nearest health center (Table 1).

Table 1. Study Variables: Description, Classification, and Sources.

Variable Description Type of variable Source of data
Sex Sex of the selected person (Male/Female). Categoric nominal Collected by trained health personnel in a questionnaire.
Age Age of the selected person (18 – 99). Continue Collected by trained health personnel in a questionnaire
Vaccine doses Total number of vaccine doses received by the selected participants. Discrete Obtain from the National Immunization Registry, or collected by trained health personnel.
Age (elderly people) Corresponds to the proportion of older adults (aged sixty-five and over) for each census block. Continuous Census 2017
Education Corresponds to the percentage of the population with a higher level of education (higher technical or university, postgraduate) for each census block. Continuous Census 2017
Overcrowding Corresponds to the rate of households where 2.5 or more people share a bedroom. This standard is defined by the National Statistics Institute (Instituto Nacional de Estadísticas, 2024) and Ministerio de Desarrollo Social (2024) Continuous Census 2017
Access to health facilities Corresponds to the distance to the nearest health center. This was determined by calculating the Euclidean distance from each census block to the nearest health center using the software QGIS Continuous Census 2017 and Chilean Ministry of Health 2024

Data sources and measurements

Individual variables (sex and age) and the number of SARS-CoV-2 vaccine doses were collected via a questionnaire completed by trained health personnel. Vaccination status was verified using a two-tier approach: (1) participants provided documentation by accessing their records through the national immunization registry portal or presenting vaccination cards; (2) when this was not feasible, participants authorized the research team to obtain records directly from the national immunization registry. Vaccination status was classified by the number of vaccine doses received as of the study date.

Statistical analysis

Spatial analysis was performed on the total number of samples from each city, separated by sex, to account for potential differences in vaccination uptake between males and females, and calls in the literature for sex-disaggregated reporting to inform more equitable vaccination programs [19,34]. A spatial autocorrelation analysis of the variable total doses was first developed for each sample (total city sample and by sex) using Moran’s Index. Moran’s spatial autocorrelation index was used because it better detects areas of concentration or dispersion across a region, whereas other indicators (such as Geary or Tango) focus more on identifying spatial outliers [35]. The index ranges from -1–1 for the statistical significance test. When the index value is positive, it indicates greater spatial concentration. Conversely, a negative value indicates greater spatial dispersion. At the same time, values closer to zero indicate homogeneity, and values closer to 1 indicate clustering. Secondly, a bivariate spatial autocorrelation analysis (Local Moran’s Index Bivariate) was conducted to assess the spatial correlation between variables [36]. For further details and formulas, see Supplementary Material Statistical analysis (S1 Appendix. Statistical analysis details and formulas). Online open software QGIS and GEODA were used to perform the analysis.

Ethical consideration

The study was conducted following the Declaration of Helsinki, and the study protocol was reviewed and approved by three independent Scientific Ethical Committees: 1) Scientific ethical committee from the Faculty of Medicine, Universidad Católica del Norte, Resolution number 63/2023, dated October 16th, 2023. 2) Scientific ethical committee from the Faculty of Medicine, Universidad del Desarrollo, dated December 13th, 2023, and 3) Scientific ethical committee from Universidad de Talca, Folio 30–2023-E, dated April 17th, 2024. Additionally, it was approved by the Institutional Committee of Biosecurity of Universidad Católica del Norte 07/2023, dated October 2023, Universidad del Desarrollo, CIB-FORM-01B, dated 14 November 2023, and Universidad de Talca 20-CBS-2023 dated November 9th, 2023. Written informed consent was obtained from all subjects involved in the study. For participants under 18 years old, an assent form was signed by the minor after their guardian signed a consent form.

Results

Participants description

Out of a total of 654 participants, 318 were from the La Serena/Coquimbo conurbation, and 336 were from Talca. The sample consists mainly of women aged over 40 with completed schooling. At the time of the study, most people had had an episode of COVID-19 and had received at least 2 vaccine doses. Vaccine data were obtained mainly from the National Immunization Registry (96%), the remaining records were obtained through the Patient Portal of the Chilean National Immunization Registry. The description of the main variables in the populations studied is presented in Table 2.

Table 2. Description of the main variables studied in terms of the city: Seroprevalence study 2024.

Variable Category La Serena/Coquimbo (n = 318) Talca

(n = 336)
n % n %
Sex Women 204 64.1 218 64.9
Men 114 35.9 118 35.1
Age 19 and less 18 5.7 7 2.1
20-39 72 22.6 68 20.2
40-59 112 35.2 114 33.9
60 and more 116 36.5 147 43.8
Education Basic or less 38 12.5 59 17.8
18 years and over Highschool 161 53.0 158 47.7
Technician 38 12.5 43 13.0
(n = 635) Professional or postgraduate 67 22.0 71 21.5
COVID-19 episodes (n = 277) Once 94 77.7 130 83.3
Twice 21 17.3 20 12.8
Three times 6 5.0 6 3.9
Vaccination history No vaccination 9 2.8 2 0.6
Basic scheme* and/or boosters (2020–2022) 182 57.2 145 43.1
Bivalent** and/or Omicron (2023–2024) 127 39.9 189 56.3

*2 doses of vaccines administered at least 28 days apart (Sinovac, Pfizer-BioNTech, AstraZeneca/Oxford).

**Pfizer-BioNTech COVID-19 Original/Omicron BA.4/BA.5 (bivalent) vaccine.

Cluster analysis in Talca

In Talca, a cluster of higher vaccine numbers is observed in the central sector of the city (Fig 2), where the highest proportion of older adults, higher educational levels, and lower overcrowding are also concentrated. However, these last two variables are not significant in the statistical analysis (Table 3). The same observations are replicated when analyzing women separately (Table 3 and S1 Fig). However, no significance is observed in the geographic distribution patterns for any of the analyzed variables in the male population (Table 3 and S2 Fig).

Fig 2. Map of the city of Talca showing the distribution of vaccine dose clustering and its associations with socio-demographic factors (age over 65, educational level, overcrowding, and distance to health center).

Fig 2

Source: Designed by the authors with data from the study. Regional boundaries were obtained from the World Bank Official Boundaries dataset (https://datacatalog.worldbank.org/search/dataset/0038272/world-bank-official-boundaries). CC-BY 4.0 license (https://datacatalog.worldbank.org/public-licenses?fragment=cc). Satellite images were sourced from the United States Geological Survey EarthExplorer platform (USGS, 2026: https://earthexplorer.usgs.gov/), which are U.S. Public Domain (https://www.usgs.gov/information-policies-and-instructions/copyrights-and-credits). Attribution is displayed in the lower right corner of each map. No proprietary mapping services were used.

Table 3. Spatial autocorrelation analysis for all population and by sex, Talca.

Variable Moran’s Index Expected index Z score P Value Conclusion
Total sample
Number of doses 0.208 0.003 2.831 0.010 Slight spatial association, significant
Elderly 0.092 -0.003 13.360 0.010 Slight spatial association, significant
Educational level 0.046 -0.003 6.697 0.001 No spatial association
Overcrowding 0.072 -0.003 -11.115 0.001 No spatial association
Distance to health center 0.005 -0.003 0.591 0.265 No spatial association
Women
Number of doses 0.158 0.005 2.763 0.014 Slight spatial association, significant
Elderly 0.113 -0.005 10.055 0.001 Slight spatial association, significant
Educational level 0.031 -0.005 3.108 0.001 No spatial association
Overcrowding -0.091 -0.005 -8.360 0.001 No spatial association
Distance to health center -0.043 -0.005 -4.094 0.001 No spatial association
Men
Number of doses -0.019 -0.008 -0.443 0.349 No spatial association
Elderly 0.054 -0.008 2.887 0.007 No spatial association
Educational level 0.012 -0.008 0.660 0.245 No spatial association
Overcrowding -0.031 -0.008 -1.623 0.461 No spatial association
Distance to health center -0.005 -0.008 0.186 0.427 No spatial association

Cluster analysis in La Serena/Coquimbo

In La Serena/Coquimbo, a cluster of higher vaccination doses is observed in the central sector of the city, which coincides with a higher proportion of more educated people, a higher proportion of older adults, and less overcrowding (Fig 3). Nevertheless, these last two variables are not significant in the statistical analysis (Table 4). The same observations are repeated when analyzing women separately (Table 4 and S3 Fig). Concerning men, the factors associated with higher vaccination rates are higher levels of schooling, a higher proportion of older adults, and overcrowding (Table 4 and S4 Fig). These last two variables were non-significant in the La Serena/Coquimbo sample and among women.

Fig 3. Map of the La Serena/Coquimbo conurbation showing the distribution of vaccine dose clustering and its associations with socio-demographic factors (age over 65, educational level, overcrowding, and distance to health center).

Fig 3

Source: Designed by the authors with data from the study. Regional boundaries were obtained from the World Bank Official Boundaries dataset (https://datacatalog.worldbank.org/search/dataset/0038272/world-bank-official-boundaries). CC-BY 4.0 license (https://datacatalog.worldbank.org/public-licenses?fragment=cc). Satellite images were sourced from the United States Geological Survey EarthExplorer platform (USGS, 2026: https://earthexplorer.usgs.gov/), which are U.S. Public Domain (https://www.usgs.gov/information-policies-and-instructions/copyrights-and-credits). Attribution is displayed in the lower right corner of each map. No proprietary mapping services were used.Table 5 summarizes the presence and absence of spatial autocorrelation for vaccine doses and bivariate correlation between vaccination and territorial variables, according to the sample type (total sample, women, and men). The difference observed between the cities is notable. The number of doses shows spatial concentration across both towns and the female samples. The distribution of older people correlates significantly with the number of doses in the Talca sample, among women in that city, and among men in the La Serena-Coquimbo conurbation. Only in that context is there a significant spatial correlation between education level and vaccination in the total sample and across both sexes. At the same time, overcrowding is spatially correlated with immunization only in the male sample of the conurbation.

Table 4. Spatial autocorrelation analysis for all population and by sex, La Serena/Coquimbo conurbation.

Variable Moran’s Index Expected index Z score P Value Conclusion
Total sample
Number of doses 0.114 -0.003 4.458 0.001 Slight spatial association, significant
Elderly 0.055 -0.003 3.375 0.001 No spatial association
Educational level 0.143 -0.003 9.001 0.001 Slight spatial association, significant
Overcrowding 0.084 -0.003 -5.391 0.001 No spatial association
Distance to health center 0.066 -0.003 4.247 0.001 No spatial association
Women
Number of doses 0.120 -0.005 3.739 0.002 Slight spatial association, significant
Elderly 0.006 -0.005 0.265 0.385 No spatial association
Educational level 0.134 -0.005 5.197 0.001 Slight spatial association, significant
Overcrowding 0.066 0.005 -2.598 0.009 No spatial association
Distance to health center 0.054 -0.005 2.168 0.017 No spatial association
Men
Number of doses 0.052 -0.009 1.148 0.126 No spatial association
Elderly 0.129 -0.009 3.235 0.002 Slight spatial association, significant
Educational level 0.135 -0.009 -3.593 0.002 Slight spatial association, significant
Overcrowding -0.144 -0.009 -2.598 0.009 Slight spatial association, significant
Distance to health center 0.064 -0.009 1.168 0.017 No spatial association

Table 5. Presence of spatial correlation by variable and type of sample.

Variable Talca total sample Talca women Talca men La Serena/Coquimbo total sample La Serena/ Coquimbo women La Serena/ Coquimbo men
Number of doses Yes Yes No Yes Yes No
Elderly Yes Yes No No No Yes
Educational level No No No Yes Yes Yes
Overcrowding No No No No No Yes
Distance to a health center No No No No No No

Discussion

The study aimed to identify geospatial vaccination distribution and factors related to post-pandemic SARS-CoV-2 vaccination in two Chilean cities. The findings show that there is some heterogeneity in the geospatial distribution of vaccination, while also confirming the hypothesis that this observation is related to socio-demographic factors in both cities. This contrasts with the homogeneous distribution previously observed in 2022 [25].

This study highlights how socio-demographic factors shape access to vaccination in the post-pandemic period, even in a country that initially achieved widespread coverage. In both cities analyzed, the high-high (HH) clusters of vaccine doses correspond to areas of lower socio-material vulnerability and the low-low (LL) clusters to areas of higher vulnerability, as evidenced by the Territorial Socio-Material Index of the UC Cities Observatory [37]. Generally, in areas of lower vulnerability, there is a higher average schooling, better housing materiality, and lower rates of overcrowding, while in areas of high vulnerability, there is less access to education and higher rates of overcrowding.

Systematic reviews and meta-analyses have reported COVID-19 vaccine hesitancy rates ranging from 42% (in Africa) to 16% (in Europe) [38], with acceptance rates also varying by country and continent, ranging from 13% (Iraq) to 92% (Tunisia) [39]. Various factors influence vaccine acceptance or hesitancy. For example, a county-level study conducted in the United States attributed 79% of the variation in vaccination rates to spatial patterns. The study shows that per capita income and the percentage of minorities have positive effects on vaccination rates, while age, mobile homes, and the uninsured population have negative effects on vaccine uptake [20]. A South African study using geo-additive models revealed geographically varying levels of vaccine hesitancy, with strong geospatial correlations between such hesitancy and beliefs [40]. Several factors associated with COVID-19 vaccine hesitancy have been identified in both conventional and geospatial studies [40,41]. One of the most significant is trust—both in the vaccine itself and in governments—where health and vaccine literacy play a key role [42–46]. Common to most of the studies reviewed is the recommendation to adapt vaccination strategies to local contexts.

In this study, Chile recorded COVID-19 vaccine acceptance rates as high as 98% at the start of the pandemic vaccination program, which subsequently declined over three years. Motivation to vaccinate and targeting COVID-19 vaccination to at-risk groups also influence the observed change over time. In this way, the study corroborates the suggestions of other researchers regarding the need to design vaccination strategies based on territorial vaccination surveillance [47], as these strategies have a greater impact on achieving high coverage [48].

Furthermore, the study contributes to the broader discussion on how vaccination campaigns should shift from emergency responses to long-term public health strategies across different global contexts, particularly in Latin America. Once the epidemiological emergency is over, socio-demographic factors such as age, sex, and education resume their influence on access to vaccination. In both cities, immunization exhibits central clustering, which may be partially explained by the higher concentration of the elderly in the center of the cities. Age was indeed a variable related to spatial distribution, although it was presented differently according to sex and city. In Talca, older adults (particularly women) were more likely to be vaccinated. This is expected, as older people are a priority group in vaccination campaigns, and because the male sample was scarce in Talca. This aligns with international studies describing higher uptake of COVID-19 vaccines in people over 45 years old [11,13].

Gender differences in vaccine uptake could partly be attributed to gender-related healthcare-seeking behaviors [49]. Chilean women tend to exhibit more proactive health-seeking behaviors [50]. Additionally, women with multiple comorbidities may have more frequent contact with healthcare centers, increasing their likelihood of vaccination. In addition, maternal care responsibilities may increase their interaction with the healthcare system, contributing to higher vaccination rates among women. A study in the United States suggests that demographic variables (age and sex) influence COVID-19 vaccination uptake more than social and economic factors [13].

In the La Serena-Coquimbo conurbation, higher education was spatially correlated with the number of vaccine doses. Health and vaccine literacy have been associated with vaccine acceptance and educational level [51,52]. COVID-19 vaccine uptake has been associated with higher economic status [11–13]. Additionally, in the conurbation’s male sample, a negative correlation was observed between the number of doses and overcrowding, reflecting lower access to vaccines in males with higher social vulnerability. This situation shows greater geographic segregation of social determinants in the conurbation compared to Talca.

Surprisingly, distance to health centers did not influence vaccination in either city, as also described in the literature [47]. This could be explained by the constant presence of health centers in the territories covering entire neighborhoods in both cities. Moreover, the low relevance of distance to health facilities confirms that structural determinants — defined here as the institutional rules, power relations, and hierarchical social arrangements that generate durable inequities among socially constructed groups [53] —still play a decisive role in shaping vaccine patterns. Within the WHO framework for social determinants of health, the health system itself operates as an intermediate determinant, mediating, but not originating, these structural forces [54].

Overall, the results show significant differences between the two cities regarding the territorial distribution of the studied variables and their relationship with COVID-19 vaccination. The differences between cities may reflect cultural factors and regional variations in attitudes toward preventive behaviors. Furthermore, it may reflect different distributions of sociodemographic factors within cities, where neighborhoods emerge that are characterized by vulnerability on the one hand and higher socioeconomic status on the other.

The research has limitations. The cross-sectional design provides only a snapshot at a given point in time, without offering insight into the evolution of disparities over longer periods. Additionally, the predominance of women in the sample may mean that the observed gender-specific disparities may not be generalizable. Socioeconomic independent variables at the census tract level (proportion elderly, educational attainment, overcrowding rate, and distance to health center) were measured at the ecological level. Therefore, this approach may introduce potential ecological fallacy, as tract-level characteristics may not reflect individual participants´ circumstances. Due to the small male sample size in Talca (n = 118), the sex-disaggregated spatial analysis may have had insufficient statistical power to detect significant spatial associations, and the absence of significant findings in this subgroup should be interpreted with caution.

Finally, as is usually the case in spatial analysis, results can only be extrapolated to cities with similar characteristics to those studied. However, it still provides information for designing vaccination campaigns or programs using a territory-based approach in cities with similar characteristics to those studied, a situation shared by cities in Chile and other Latin American countries. The minimum set of variables to consider is the population’s age, sex, and socioeconomic distribution to ensure greater equity in access to vaccination.

All the above suggest that future research should contemplate, for example, longitudinal studies to understand the dynamics of vaccination processes and their determinants, qualitative research to complement the geospatial analysis, comparative studies in different contexts or countries to make the results more generalizable, or studies to evaluate interventions or the impact of specific vaccination policies.

Recommendations arising from the results are: first, implementing geospatial surveillance systems integrated with demographic and social data sources. Second, vaccination strategies should be tailored to local contexts, accounting for demographic (sex, age) and social variables (vulnerability, educational level). Third, long-term strategies to improve health literacy and build trust in health institutions are needed to enhance access to vaccination programs. Fourth, transition plans from emergency mass vaccination to routine immunization programs should be developed proactively to anticipate and address the re-emergence of disparities.

Conclusions

The hypothesis that there is a heterogeneous geospatial distribution of vaccination associated with socio-demographic factors after the end of the epidemic emergency is confirmed.

The study provides useful insights for policymakers and public health officials who are responsible for designing more effective and equitable public health strategies worldwide. It demonstrates the complex transition from emergency vaccination to epidemic control to a long-term sustainable response through vaccination programs. Such a transition requires proactive, adaptive, and data-driven strategies to achieve equitable immunization. Consequently, vaccination strategies need to be adapted using a territorial approach, considering the complex relationships among socio-demographic factors and unique local contexts.

Supporting information

S1 Appendix. Statistical analysis details and formulas.

(PDF)

pgph.0006808.s001.pdf (817.5KB, pdf)
S1 Fig. Maps of Talca city showing the distribution of vaccine dose clustering in women and its associations with socio-demographic factors (age over 65, educational level, overcrowding, and distance to health center).

Regional boundaries and road networks were obtained from the Chilean National Statistics Institute (Instituto Nacional de Estadísticas, INE Chile) open geodata repository (https://www.ine.gob.cl/herramientas/portal-de-mapas/geodatos-abiertos. CC-BY 4.0 license: https://www.ine.gob.cl/terminos-de-uso-y-licencia-de-datos-abiertos.

(TIF)

pgph.0006808.s002.tif (2.6MB, tif)
S2 Fig. Map of Talca city showing the distribution of vaccine dose clustering in men and its associations with socio-demographic factors (age over 65, educational level, overcrowding, and distance to health center).

Regional boundaries and road networks were obtained from the Chilean National Statistics Institute (Instituto Nacional de Estadísticas, INE Chile) open geodata repository (https://www.ine.gob.cl/herramientas/portal-de-mapas/geodatos-abiertos. CC-BY 4.0 license: https://www.ine.gob.cl/terminos-de-uso-y-licencia-de-datos-abiertos.

(TIF)

pgph.0006808.s003.tif (2.6MB, tif)
S3 Fig. Map of the La Serena/Coquimbo conurbation showing the distribution of vaccine dose clustering in women and its associations with socio-demographic factors (age over 65, educational level, overcrowding, and distance to health center).

Regional boundaries and road networks were obtained from the Chilean National Statistics Institute (Instituto Nacional de Estadísticas, INE Chile) open geodata repository (https://www.ine.gob.cl/herramientas/portal-de-mapas/geodatos-abiertos. CC-BY 4.0 license: https://www.ine.gob.cl/terminos-de-uso-y-licencia-de-datos-abiertos.

(TIF)

pgph.0006808.s004.tif (2.1MB, tif)
S4 Fig. Map of La Serena/Coquimbo conurbation showing the distribution of vaccine dose clustering in men and its associations with socio-demographic factors (age over 65, educational level, overcrowding, and distance to health center).

Regional boundaries and road networks were obtained from the Chilean National Statistics Institute (Instituto Nacional de Estadísticas, INE Chile) open geodata repository (https://www.ine.gob.cl/herramientas/portal-de-mapas/geodatos-abiertos. CC-BY 4.0 license: https://www.ine.gob.cl/terminos-de-uso-y-licencia-de-datos-abiertos.

(TIF)

pgph.0006808.s005.tif (2.1MB, tif)

Acknowledgments

The authors acknowledge all participants who voluntarily contributed their blood samples and completed the questionnaire essential to this research. We appreciate the field personnel, including health students, nurses, and field coordinators, whose dedication and technical expertise were invaluable to the successful implementation of this study.

Data Availability

Data Availability Statement: The data for the study can be accessible from https://doi.org/10.5281/zenodo.16365760.

Funding Statement

This research was funded by the Chilean National Research Agency (https://anid.cl/), Grant code FONIS SA23I0063. The Chilean Ministry of Health provided nasal swab tests to identify SARS-CoV-2 antigens. The author LN-F received the Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1.Pelloso FC, Pazin DC, Silva LL, Carvalho MDB, Borghesan DHP, Consolaro MEL, et al. HPV vaccination coverage in Brazil’s State of Paraná: Spatial distribution and advances in public health. Vaccines (Basel). 2024;12(10):1118. doi: 10.3390/vaccines12101118 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.de Aguiar Pontes Pamplona Y, do Nascimento AMV, de Olinda RA, Barbieri CLA, Braga ALF, Martins LC. Spatial analysis of measles vaccination coverage in the State of São Paulo. BMC Public Health. 2023;23(1):29. doi: 10.1186/s12889-022-14797-z [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Wheeler DC, Miller CA, Do EK, Ksinan AJ, Trogdon JG, Chukmaitov A, et al. Identifying area-level disparities in human papillomavirus vaccination coverage using geospatial analysis. Cancer Epidemiol Biomarkers Prev. 2021;30(9):1689–96. doi: 10.1158/1055-9965.EPI-21-0331 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Al-Kassab-Córdova A, Silva-Perez C, Maguiña JL. Spatial distribution, determinants and trends of full vaccination coverage in children aged 12-59 months in Peru: A subanalysis of the Peruvian Demographic and Health Survey. BMJ Open. 2022;12(11):e050211. doi: 10.1136/bmjopen-2021-050211 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Tesfa GA, Demeke AD, Hailegebreal S, Amede ES, Ngusie HS, Kasie MN, et al. Spatial distribution and associated factors of measles vaccination among children aged 12-23 months in Ethiopia. A spatial and multilevel analysis. Hum Vaccin Immunother. 2022;18(1):2035558. doi: 10.1080/21645515.2022.2035558 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Bilgel F, Karahasan BC. Effects of vaccination and the spatio-temporal diffusion of Covid-19 incidence in Turkey. Geogr Anal. 2022;:10.1111/gean.12335. doi: 10.1111/gean.12335 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Agegnehu CD, Alem AZ. Exploring spatial variation in BCG vaccination among children 0-35 months in Ethiopia: Spatial analysis of Ethiopian Demographic and Health Survey 2016. BMJ Open. 2021;11(4):e043565. doi: 10.1136/bmjopen-2020-043565 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Agimas MC, Asmamaw M, Hailu MK, Kidie T, Abuhay HW, Yismaw GA, et al. Geospatial mapping to assess the distribution and determinants of zero dose vaccination status hot spots among children in Ethiopia using EDHS 2019: Spatial and geographical weighted regression. PLoS One. 2024;19(12):e0312610. doi: 10.1371/journal.pone.0312610 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Ogero M, Orwa J, Odhiambo R, Agoi F, Lusambili A, Obure J, et al. Pentavalent vaccination in Kenya: Coverage and geographical accessibility to health facilities using data from a community demographic and health surveillance system in Kilifi County. BMC Public Health. 2022;22(1):826. doi: 10.1186/s12889-022-12570-w [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Montero DA, Vidal RM, Velasco J, Torres JP, O MAB, Angel AO. Two centuries of vaccination: Historical and conceptual approach and future perspectives. Journal of Vaccination. 2023;10(1):1–10. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Faes C, Molenberghs G, Hens N, Van Bortel L, Vandeboel N, Pellens K, et al. Geographical variation of COVID-19 vaccination coverage, ethnic diversity and population composition in Flanders. Vaccine X. 2022;11:100194. doi: 10.1016/j.jvacx.2022.100194 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Chen H, Cao Y, Feng L, Zhao Q, Torres JRV. Understanding the spatial heterogeneity of COVID-19 vaccination uptake in England. BMC Public Health. 2023;23(1):895. doi: 10.1186/s12889-023-15801-w [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Yang T-C, Matthews SA, Sun F. Multiscale dimensions of spatial process: COVID-19 fully vaccinated rates in U.S. counties. Am J Prev Med. 2022;63(6):954–61. doi: 10.1016/j.amepre.2022.06.006 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Huang Q, Cutter SL. Spatial-temporal differences of COVID-19 vaccinations in the U.S. Urban Inform. 2022;1(1):19. doi: 10.1007/s44212-022-00019-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Wolde HF, Clements ACA, Gilmour B, Alene KA. Spatial co-distribution of tuberculosis prevalence and low BCG vaccination coverage in Ethiopia. Sci Rep. 2024;14(1):31561. doi: 10.1038/s41598-024-68549-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Tandy CB, Odoi A. Geographic disparities and predictors of vaccination exemptions in Florida: A retrospective study. PeerJ. 2022;10:e12973. doi: 10.7717/peerj.12973 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Atalell KA, Alemayehu MA, Teshager NW, Belay GM, Alemu TG, Anlay DZ, et al. Mapping BCG vaccination coverage in Ethiopia between 2000 and 2019. BMC Infect Dis. 2022;22(1):569. doi: 10.1186/s12879-022-07547-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Nizigiyimana A, Acharya D, Morillon G. Predictors of vaccine acceptance, confidence, and hesitancy in general, and COVID-19 vaccination refusal in the province of Quebec, Canada. 2022;:2181–202. doi: 10.2147/PPA.S376103 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Evagora-Campbell M, Borkotoky K, Sharma S, Mbuthia M. From routine data collection to policy design: Sex and gender both matter in COVID-19. Lancet. 2021;397(10293):2447–9. doi: 10.1016/S0140-6736(21)01326-X [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Mollalo A, Tatar M. Spatial modeling of COVID-19 vaccine hesitancy in the United States. Int J Environ Res Public Health. 2021;18(18):9488. doi: 10.3390/ijerph18189488 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Waterschoot J, Vansteenkiste M, Yzerbyt V, Morbée S, Klein O, Luminet O, et al. Risk perception as a motivational resource during the COVID-19 pandemic: The role of vaccination status and emerging variants. BMC Public Health. 2024;24(1):731. doi: 10.1186/s12889-024-18020-z [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Ministerio de Salud de Chile. Fin alerta sanitaria covid: ¿Qué pasa con teletrabajo y mascarillas?. https://www.gob.cl/noticias/fin-alerta-sanitaria-covid-19-coronavirus-enfermedades-respiratorias-mascarillas-teletrabajo/. 2023. Accessed 2026 May 31.
  • 23.Núñez-Franz L, Ramírez-Santana M, Rubilar P, Vial C, Apablaza M, González C. Seroprevalence of Natural and Acquired Immunity against the SARS-CoV-2 Virus in a Population Cohort from Two Chilean Cities, 2020–2022. Viruses. 2023;15:2020–2. doi: 10.3390/v15010201 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Mena GE, Martinez PP, Mahmud AS, Marquet PA, Buckee CO, Santillana M. Socioeconomic status determines COVID-19 incidence and related mortality in Santiago, Chile. Science. 2021;372(6545):eabg5298. doi: 10.1126/science.abg5298 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Ramírez-Santana M, Correa J, Franz LN, Apablaza M, Rubilar P, Vial C. Overcoming health inequities: Spatial analysis of seroprevalence and vaccination against COVID-19 in Chile. Health Equity. 2024;8:558–67. doi: 10.1089/heq.2023.0204 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.World Health Organization. COVID-19 Vaccines Advice. 2024. [cited 28 May 2026]. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/covid-19-vaccines/advice
  • 27.Ministerio de Salud de Chile. Plan Nacional de Vacunacion COVID-19. 2022. https://www.minsal.cl/covid-19-se-han-administrado-mas-de-57-millones-372-mil-dosis-de-la-vacuna-contra-sars-cov-2/
  • 28.Nuñez-Franz L, Rubilar P, Apablaza M, Canales L, Cortés LJ, Molina X, et al. Population-based seroprevalence survey: Post-pandemic COVID-19 vaccination, related factors, and geographic distribution of vaccine acceptability in Chile. BMC Public Health. 2025;25(1):1176. doi: 10.1186/s12889-025-22314-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Sommers T, Dockery M, Burke N, D’Souza S, Troupe B, Agbonyinma T, et al. Building trust and equity in vaccine communication through community engagement. Hum Vaccin Immunother. 2025;21(1):2518636. doi: 10.1080/21645515.2025.2518636 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Estadísticas I nacional de censo de población y vivienda 2017. Instituto Nacional de Estadísticas. 2017. https://redatam-ine.ine.cl/
  • 31.Instituto Nacional de Estadísticas. Censo de población y vivienda 2017. Santiago: Instituto Nacional de Estadísticas. https://redatam-ine.ine.cl/
  • 32.Observatorio Social - Ministerio de Desarrollo Social y Familia. https://observatorio.ministeriodesarrollosocial.gob.cl/encuesta-casen-2024. Accessed 2026 May 29.
  • 33.Estadisticas I de. Síntesis de resultados censo 2024. 2024. https://censo2024.ine.gob.cl/wp-content/uploads/2025/12/sintesis_resultados_censo2024.pdf
  • 34.Vijayasingham L, Bischof E, Wolfe J, Gender and COVID-19 Research Agenda-setting Initiative. Sex-disaggregated data in COVID-19 vaccine trials. Lancet. 2021;397(10278):966–7. doi: 10.1016/S0140-6736(21)00384-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Anselin L. Local indicators of spatial association—LISA. Geogr Anal. 1995;27:93–115. doi: 10.1111/j.1538-4632.1995.tb00338.x [DOI] [Google Scholar]
  • 36.Lee S-I. Developing a bivariate spatial association measure: An integration of Pearson’s r and Moran’s I. Journal of Geographical Systems. 2001;3(4):369–85. doi: 10.1007/s101090100064 [DOI] [Google Scholar]
  • 37.Araya MR. Calculating Socio Material Territorial Index. CRAN. 2023. 10.32614/CRAN.PACKAGE.ISMTCHILE [DOI] [Google Scholar]
  • 38.Zhao T, Xu Q, Cai X, Wang M, Ao L, Wei T, et al. Global spatio-temporal distribution of coronavirus disease 2019 vaccine hesitancy between 2020 and 2022: A meta-analysis. Vaccine. 2025;53:126933. doi: 10.1016/j.vaccine.2025.126933 [DOI] [PubMed] [Google Scholar]
  • 39.Sallam M, Al-sanafi M, Sallam M. A global map of COVID-19 vaccine acceptance rates per country: An updated concise narrative review. J Multidiscip Health. 2022. doi: 10.2147/JMDH.S347669 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Wand H, Moodley J, Derrick K, Vujovich-Dunn C, Reddy T, Naidoo S. Evaluating the impact of public health messages for COVID-19 vaccine hesitancy in South Africa: Temporal versus geospatial trends (2021–2022). J Public Health (Berl). 2023;33(5):1071–83. doi: 10.1007/s10389-023-02072-3 [DOI] [Google Scholar]
  • 41.Rahbeni TA, Satapathy P, Itumalla R, Marzo RR. COVID-19 vaccine hesitancy: Umbrella review of systematic reviews and meta-analysis. 2024. 10.2196/54769 [DOI] [PMC free article] [PubMed]
  • 42.Carrieri V, Guthmuller S, Wübker A. Trust and COVID-19 vaccine hesitancy. Sci Rep. 2023;13(1):9245. doi: 10.1038/s41598-023-35974-z [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Romate J, Rajkumar E, Gopi A, Abraham J, Rages J, Lakshmi R, et al. What contributes to COVID-19 vaccine hesitancy? A systematic review of the psychological factors associated with COVID-19 vaccine hesitancy. 2022;:1–21. 10.3390/vaccines10111777 [DOI] [PMC free article] [PubMed]
  • 44.Jennings W, Valgarðsson V, McKay L, Stoker G, Mello E, Baniamin HM. Trust and vaccine hesitancy during the COVID-19 pandemic: A cross-national analysis. Vaccine X. 2023;14:100299. doi: 10.1016/j.jvacx.2023.100299 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Roy ND, Biswas M, Islam E, Azam S. Potential factors influencing COVID-19 vaccine acceptance and hesitancy: A systematic review. PLoS One. 2022;:1–20. doi: 10.1371/journal.pone.0265496 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Pourrazavi S, Fathifar Z, Sharma M, Allahverdipour H. COVID-19 vaccine hesitancy: A Systematic review of cognitive determinants. Health Promot Perspect. 2023;13(1):21–35. doi: 10.34172/hpp.2023.03 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Mohammadi A, Mollalo A, Bergquist R, Kiani B. Measuring COVID-19 vaccination coverage: An enhanced age-adjusted two-step floating catchment area model. Infect Dis Poverty. 2021;10(1):118. doi: 10.1186/s40249-021-00904-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Ghazal I, Rachadi A, Ez-Zahraouy H. Optimal allocation strategies for prioritized geographical vaccination for Covid-19. Physica A. 2022;607:128166. doi: 10.1016/j.physa.2022.128166 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Thompson AE, Anisimowicz Y, Miedema B, Hogg W, Wodchis WP, Aubrey-Bassler K. The influence of gender and other patient characteristics on health care-seeking behaviour: A QUALICOPC study. BMC Fam Pract. 2016;17:38. doi: 10.1186/s12875-016-0440-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Rubilar P, Nuñez-Franz L, Apablaza M, Ramirez-Santana M, Molina X. Preventive behaviors for COVID-19 in Chile: Lessons from a population follow-up for 2021 and 2022. Medwave. 2024;24:e2939. doi: 10.5867/medwave.2024.10.2939 [DOI] [PubMed] [Google Scholar]
  • 51.Badua AR, Caraquel KJ, Cruz M, Narvaez RA. Vaccine literacy: A concept analysis. Int J Ment Health Nurs. 2022;31(4):857–67. doi: 10.1111/inm.12988 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Biasio LR, Zanobini P, Lorini C, Monaci P, Fanfani A, Gallinoro V, et al. COVID-19 vaccine literacy: A scoping review. Hum Vaccin Immunother. 2023;19(1):2176083. doi: 10.1080/21645515.2023.2176083 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Heller JC, Givens ML, Johnson SP, Kindig DA. Keeping it political and powerful: Defining the structural determinants of health. Milbank Q. 2024;102(2):351–66. doi: 10.1111/1468-0009.12695 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Solar O, Irwin A. A Conceptual Framework for Action on the Social Determinants of Health. World Health Organization. 2022. https://www.who.int/publications/i/item/9789241500852 [Google Scholar]
PLOS Glob Public Health. doi: 10.1371/journal.pgph.0006808.r001

Decision Letter 0

Eugene T Richardson

16 Sep 2025

-->-->-->PGPH-D-25-02096-->-->Geospatial disparities in post-pandemic SARS-CoV-2 vaccination: Evidence from Chile beyond the national success-->-->PLOS Global Public Health

Dear Dr. Núñez-Franz,

Thank you for submitting your manuscript to PLOS Global Public Health. After careful consideration, we have decided that your manuscript does not meet our criteria for publication and must therefore be rejected.

Specifically:

==============================-->-->While the Methods are adequate for conducting a population-based seroprevalence survey (as published previously by some of the co-authors), the number of SARS-CoV-2 vaccine doses can be very poorly captured by participant report. It is therefore not a rigorous enough approach to data collection for this key variable to accept the conclusions presented (#4 in PLOS GPH Criteria for Publication).-->

==============================

We are sorry that we cannot be more positive on this occasion. We very much appreciate your wish to present your work in one of PLOS's Open Access publications. Thank you for your support, and we hope that you will consider PLOS Global Public Health for other submissions in the future.

Yours sincerely,

Eugene T. Richardson, MD, PhD

Academic Editor

PLOS Global Public Health

Additional Editor Comments (if provided):

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

-->-->

PLOS Glob Public Health. doi: 10.1371/journal.pgph.0006808.r003

Decision Letter 1

Abram L Wagner

5 May 2026

PGPH-D-25-02096R1

Geospatial disparities in post-pandemic SARS-CoV-2 vaccination: Evidence from Chile beyond the national success

PLOS Global Public Health

Dear Dr. Núñez-Franz,

Thank you for submitting your manuscript to PLOS Global Public Health. After careful consideration, we feel that it has merit but does not fully meet PLOS Global Public Health’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please respond to reviewer comments, but let us know in your response if you do not feel the need to respond to a particular comment. Please also be aware, that as I review your response, I'll also keep in mind the previous editors' comment - addressing that in your response, too, would be helpful:

While the Methods are adequate for conducting a population-based seroprevalence survey (as published previously by some of the co-authors), the number of SARS-CoV-2 vaccine doses can be very poorly captured by participant report. It is therefore not a rigorous enough approach to data collection for this key variable to accept the conclusions presented.

Please submit your revised manuscript by Jul 04 2026 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at globalpubhealth@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pgph/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A letter that responds to each point raised by the editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

As the corresponding author, your ORCID iD is verified in the submission system and will appear in the published article. PLOS supports the use of ORCID, and we encourage all coauthors to register for an ORCID iD and use it as well. Please encourage your coauthors to verify their ORCID iD within the submission system before final acceptance, as unverified ORCID iDs will not appear in the published article. Only  the individual author can complete the verification step; PLOS staff cannot  verify ORCID iDs on behalf of authors.

We look forward to receiving your revised manuscript.

Kind regards,

Abram L. Wagner, PhD, MPH

Academic Editor

PLOS Global Public Health

Journal Requirements:

If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise.

Additional Editor Comments (if provided):

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

-->Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.-->

Reviewer #1: All comments have been addressed

Reviewer #2: (No Response)

Reviewer #3: (No Response)

Reviewer #4: All comments have been addressed

**********

-->2. Does this manuscript meet PLOS Global Public Health’s publication criteria? Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe methodologically and ethically rigorous research with conclusions that are appropriately drawn based on the data presented.-->

Reviewer #1: Yes

Reviewer #2: Partly

Reviewer #3: Partly

Reviewer #4: Yes

**********

-->3. Has the statistical analysis been performed appropriately and rigorously?-->

Reviewer #1: I don't know

Reviewer #2: (No Response)

Reviewer #3: I don't know

Reviewer #4: Yes

**********

-->4. Have the authors made all data underlying the findings in their manuscript fully available (please refer to the Data Availability Statement at the start of the manuscript PDF file)?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception. The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.-->

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

Reviewer #4: No

**********

-->5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS Global Public Health does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.-->

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

Reviewer #4: Yes

**********

-->6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)-->

Reviewer #1: This manuscript explores the geospatial disparities in post-pandemic SARS-CoV-2 vaccination in Chile, providing valuable insights that can be used in public health control of infectious diseases.

The proposed framework has potential applicability to research on understanding health behavior in relation to other regions and other diseases, particularly emerging and re-emerging infections.

The authors deserve appreciation for the work that they put into designing the experiments and collecting the data using proper channels and in compliance with ethical considerations.

Certain claims could benefit from references to existing literature, thus lending more credibility to the research process (e.g., Line 56, Line 58, Line 90, Line 103, Line 126).

Please describe the variables used in relation to the categories that they belong to. For example, whether they are discrete or continuous.

More information regarding the statistical test (including any formulas) should be provided under the dedicated section “Statistical analysis”. Spatial autocorrelation analysis needs to be defined properly with sufficient information. All statistical methods used should be described in this section, including the Moran’s Index, Expected index, Z score, and P Value with reference to the context of the study.

The manuscript seems to lack graphical illustrations; while not necessary, it would be better to include a few figures effectively communicating the statistical results.

While not necessary, the authors could discuss how the proposed framework could be adapted to other regions or international contexts as part of future research.

It is better to number the sections on the manuscript to improve its readability and navigation.

Please carefully review the specific points below and revise the manuscript accordingly.

Lines 60-64: Is employment or profession not a considerable factor?

Lines 71-72: Better to restructure this sentence in the past tense.

Line 80: Missing reference.

Line 82: Please revise as “specific population groups who are at more risk”.

Line 83: Change “good coverage” to “sufficient vaccination coverage”?

Line 91: Change “geospatial vaccination distribution post-pandemic SARS-CoV-2 vaccination” to “geospatial distribution of post-pandemic SARS-CoV-2 vaccination”?

Lines 94-95: Please rephrase for clarity.

Line 103: Change to past tense?

Line 114 and more: Links may not be appropriate on the main text. Please check with the journal instructions.

Line 144: Is the phrase “than expected” necessary?

Line 179: Change “by city” to “in terms of the city”?

Table 1: Change “No vaccinated” to “No vaccination” or “Unvaccinated”?

Line 187: Change “masculine” to “men’s” or “male”?

Line 226: Change “in both” to “across both”?

Line 240: Isn't the heterogeneity itself a finding of the study? So, how about phrasing the sentence as follows? "The findings show that there is some heterogeneity in the geospatial distribution of vaccination, while also confirming the hypothesis that this observation is related to socio-demographic factors in both cities."

Lines 245-246: Would it be possible to plot a figure to illustrate this result?

Line 248: Are the correlations strong enough to warrant the use of the word “precisely”? If not, it would be better to use a different word such as "generally".

Line 282: Is the correlation with the number of doses really negative?

Lines 286-287: Change “as described” to “as also described”?

Line 290: Use a more appropriate adjective instead of “deeper”?

Line 315: Change “develop” to “developing”?

Line 319: Change “re-emerge” to “re-emergence”?

Overall, the manuscript is commendable and will be a valuable addition to the relevant literature.

Reviewer #2: General comment

The topic is timely and relevant, and the Chilean context provides a valuable comparative lens given the country’s initially equitable vaccination performance during the pandemic. The study addresses an important gap in understanding post-pandemic vaccination dynamics and offers useful insights into emerging socio-spatial disparities.

Major Comments

1. The "WHO recommendations (reference)" placeholder

In the Introduction (line 80), the sentence reads: "Following the WHO recommendations (reference), since 2023 the Chilean Ministry of Health…" The citation marked "(reference)" remains unfilled. This should be corrected before publication.

2. Disconnect between individual-level data and census-level independent variables

The study collects individual-level data on vaccination (number of doses per person), then assigns socio-demographic independent variables at the census tract level (proportion elderly, educational attainment, overcrowding rate, distance to health center). This is a form of ecological analysis applied to individual-level outcomes, which creates the potential for an ecological fallacy tract-level characteristics may not reflect the individual participant's circumstances. This is not acknowledged in the limitations section, and readers should be cautioned against inferring individual-level causal relationships from these associations. The authors should either address this limitation or, if they consider their analytical approach to sufficiently mitigate it, explain why.

3. Inconsistency in the "Conclusion" column of Tables 2 and 3

There are inconsistencies in the interpretation of spatial autocorrelation results. Several variables with statistically significant p-values (p < 0.05) are described as having “no spatial association,” despite evidence of weak but significant spatial autocorrelation based on Moran’s I. The manuscript would benefit from a clearer distinction between statistical significance (p-value) and strength of association (magnitude of Moran’s I). Even small Moran’s I values, when statistically significant, indicate non-random spatial structure and should be interpreted accordingly (e.g., “weak but significant spatial association”).

4. Interpretation of age-related findings in La Serena/Coquimbo

The interpretation of the age-related findings for La Serena/Coquimbo requires clarification. The results indicate that the proportion of older adults is not spatially associated with vaccination in the total sample or among women, but is associated among men (Table 3; Results section around lines 202–209).

However, the Discussion suggests that clusters of adults younger than 65 receiving more vaccine doses may reflect workplace vaccination access (lines 267–269). This explanation appears speculative, as the study does not include occupational data, workplace vaccination records, or variables capturing access through employment.

This interpretation should either be removed or clearly framed as a hypothesis requiring further investigation. The manuscript should avoid attributing observed spatial patterns to mechanisms not supported by the available data..

5. Sample size and sex-disaggregated analysis

The male sub-samples particularly for Talca (n = 118) are modest. The authors acknowledge the male sample was "scarce in Talca" (Discussion, line 265) but do not address the statistical implications for the sex-disaggregated spatial analyses. With a small and spatially distributed male sample, the absence of significant spatial associations in the Talca male sub-sample may reflect limited statistical power rather than a true absence of spatial patterning. This should be discussed explicitly as a limitation rather than treated symmetrically with the female and total sample results.

6. Two-tier vaccination verification: incomplete manuscript integration

The manuscript describes a two-tier approach for verifying vaccination status (participant-provided documentation and registry confirmation with authorization; lines 129-135). While this strengthens confidence in the data collection process, the reporting remains largely procedural.

The manuscript does not provide a quantitative breakdown of how many participants were verified through each method, nor does it report any instances of missing, unverifiable, or incomplete records.

Given that vaccination status is the primary outcome, greater transparency on data verification and completeness would strengthen the credibility of the findings. A concise quantitative summary of the verification process should be included in the manuscript, rather than only in the response letter.

Minor Comments

• Line 80 (Introduction): The phrase "vaccination coverage is also deteriorating" (present tense) in a description of trends since 2023 is grammatically inconsistent with the surrounding paragraph. Suggest: "vaccination coverage has also been deteriorating."

• Table 1: The total for Talca is listed as n = 336 in the table header, but n = 335 in the Results text (line 161). This discrepancy should be resolved.

• Lines 315-316 (Recommendations): The sentence "Third, develop long-term strategies to improve health literacy and trust-building initiatives may improve the access to vaccination programs" is grammatically incomplete. This may be revised as follows “ Third, long-term strategies to improve health literacy and build trust may enhance access to vaccination programs.”

• Reference 9 is an exact duplicate of Reference 5 (Tesfa GA et al., PLoS One 2023, doi:10.1371/journal.pone.0279399). One should be removed or replaced with the intended citation.

Conclusion and recommendation

Major revision required. The manuscript addresses an important and underexplored topic, and the Chilean context provides a compelling natural experiment for studying the post-pandemic re-emergence of socio-demographic determinants of vaccination. However, the comments outlined above need to be resolved before the paper meets PLOS Global Public Health's publication criteria.

Reviewer #3: Overall: The topic and geospatial approach are relevant and important. However, the authors have not sufficiently justified the approach and some of the objectives are not clear.

lines 61-64: The fragmentation of the referencing here affects the flow of the sentence and can be improved by regrouping the factors with same references so they can be cited together. e.g. age and insurance status [14, 18]. instead of age [14.18], and insurance status [18].

Line 80: No reference included for the WHO recommendation

lines 83-85: This information is important, as it describes post-pandemic vaccine hesitancy, however, I expect also to see why vaccination is still expected or seen to be important in Chile in 2024.

line 91/table 1 and across the paper: It is not clear in this paper what represents the post-pandemic period. This is also important in understanding the vaccine doses reported because some of the doses may have been taken in the pandemic period.

92-93: justification for choosing these cities.

105-108: how were the samples collected, transported and stored? what type of test was done.

130-135: how reliable are these different sources of vaccination records and how do they compare?

The analysis by sex is good. However, the background and objectives did not give any indication of importance or interest in the disparities by sex.

Linea 155-156: what is the reference that informs this cut off for overcrowding?

Table 1: What vaccines constitutes the basic scheme? Please specify the bivalent types or explain briefly in a footnote.

Line 180 (table 1) and other tables: This may not be necessary. Stating sources is more important if the source is from a different study or secondary data.

Tables 2 and 3: what determines if an association is slight spatial association? What are the other categories of spatial associations?

Lines 237-331: In this discussion, I expect a synthesis that compares and contrast with post-pandemic hesitancy in other countries particularly of the some geographic and/or socioeconomic similarities. Where possible, discussion should also highlight similar geospatial approaches from other studies on COVID-19 or other vaccines used in pandemics or epidemics

Reviewer #4: The manuscript addresses a very important issue of public health significance - sustaining equitable vaccine coverage following pandemics. The message is clear, convincing, and backed by sufficient evidence, which is fairly well referenced. Some English language editing of the manuscript is required.

**********

-->7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

Do you want your identity to be public for this peer review?  If you choose “no”, your identity will remain anonymous but your review may still be made public.

For information about this choice, including consent withdrawal, please see our Privacy Policy.-->

Reviewer #1: Yes:  I. M. Hewage

Reviewer #2: No

Reviewer #3: No

Reviewer #4: Yes:  Ayodeji O. OLARINMOYE

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

-->Figure Resubmissions:

-->-->While revising your submission, we strongly recommend that you use PLOS’s NAAS tool (https://ngplosjournals.pagemajik.ai/artanalysis) to test your figure files. NAAS can convert your figure files to the TIFF file type and meet basic requirements (such as print size, resolution), or provide you with a report on issues that do not meet our requirements and that NAAS cannot fix.-->-->

After uploading your figures to PLOS’s NAAS tool - https://ngplosjournals.pagemajik.ai/artanalysis, NAAS will process the files provided and display the results in the "Uploaded Files" section of the page as the processing is complete. If the uploaded figures meet our requirements (or NAAS is able to fix the files to meet our requirements), the figure will be marked as "fixed" above. If NAAS is unable to fix the files, a red "failed" label will appear above. When NAAS has confirmed that the figure files meet our requirements, please download the file via the download option, and include these NAAS processed figure files when submitting your revised manuscript.-->

PLOS Glob Public Health. doi: 10.1371/journal.pgph.0006808.r005

Decision Letter 2

Abram L Wagner

3 Jun 2026

PGPH-D-25-02096R2

Geospatial disparities in post-pandemic SARS-CoV-2 vaccination: Evidence from Chile beyond the national success

PLOS Global Public Health

Dear Dr. Núñez-Franz,

Thank you for submitting your manuscript to PLOS Global Public Health. After careful consideration, we feel that it has merit but does not fully meet PLOS Global Public Health’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Jul 03 2026 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at globalpubhealth@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pgph/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A letter that responds to each point raised by the editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

As the corresponding author, your ORCID iD is verified in the submission system and will appear in the published article. PLOS supports the use of ORCID, and we encourage all coauthors to register for an ORCID iD and use it as well. Please encourage your coauthors to verify their ORCID iD within the submission system before final acceptance, as unverified ORCID iDs will not appear in the published article. Only  the individual author can complete the verification step; PLOS staff cannot  verify ORCID iDs on behalf of authors.

We look forward to receiving your revised manuscript.

Kind regards,

Abram L. Wagner, PhD, MPH

Academic Editor

PLOS Global Public Health

Journal Requirements:

If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise.

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

Additional Editor Comments (if provided):

I have found you responded well to reviewers. As the editor, I just have one larger question. What do you mean by "structural issues"? The word "structural," in my mind, encompasses distance to clinic - which you list as something which is not structural in page 18 line 320. Essentially, I think you need to slightly discuss structural and social determinants a bit more - or at least define them more precisely - in the discussion. I would think this is a minor change, and I will be able to process your manuscript rapidly with these edits - or a response to me if you do not think edits are warranted.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

--> -->-->Figure Resubmissions:

-->-->While revising your submission, we strongly recommend that you use PLOS’s NAAS tool (https://ngplosjournals.pagemajik.ai/artanalysis) to test your figure files. NAAS can convert your figure files to the TIFF file type and meet basic requirements (such as print size, resolution), or provide you with a report on issues that do not meet our requirements and that NAAS cannot fix.-->-->

After uploading your figures to PLOS’s NAAS tool - https://ngplosjournals.pagemajik.ai/artanalysis, NAAS will process the files provided and display the results in the "Uploaded Files" section of the page as the processing is complete. If the uploaded figures meet our requirements (or NAAS is able to fix the files to meet our requirements), the figure will be marked as "fixed" above. If NAAS is unable to fix the files, a red "failed" label will appear above. When NAAS has confirmed that the figure files meet our requirements, please download the file via the download option, and include these NAAS processed figure files when submitting your revised manuscript.-->

PLOS Glob Public Health. doi: 10.1371/journal.pgph.0006808.r007

Decision Letter 3

Abram L Wagner

19 Jun 2026

Geospatial disparities in post-pandemic SARS-CoV-2 vaccination: Evidence from Chile beyond the national success

PGPH-D-25-02096R3

Dear Núñez-Franz,

We are pleased to inform you that your manuscript 'Geospatial disparities in post-pandemic SARS-CoV-2 vaccination: Evidence from Chile beyond the national success' has been provisionally accepted for publication in PLOS Global Public Health.

Before your manuscript can be formally accepted you will need to complete some formatting changes, which you will receive in a follow up email. A member of our team will be in touch with a set of requests.

Please note that your manuscript will not be scheduled for publication until you have made the required changes, so a swift response is appreciated.

IMPORTANT: The editorial review process is now complete. PLOS will only permit corrections to spelling, formatting or significant scientific errors from this point onwards. Requests for major changes, or any which affect the scientific understanding of your work, will cause delays to the publication date of your manuscript.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they'll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact globalpubhealth@plos.org.

Thank you again for supporting Open Access publishing; we are looking forward to publishing your work in PLOS Global Public Health.

Best regards,

Abram L. Wagner, PhD, MPH

Academic Editor

PLOS Global Public Health

***********************************************************

Reviewer Comments (if any, and for reference):

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Appendix. Statistical analysis details and formulas.

    (PDF)

    pgph.0006808.s001.pdf (817.5KB, pdf)
    S1 Fig. Maps of Talca city showing the distribution of vaccine dose clustering in women and its associations with socio-demographic factors (age over 65, educational level, overcrowding, and distance to health center).

    Regional boundaries and road networks were obtained from the Chilean National Statistics Institute (Instituto Nacional de Estadísticas, INE Chile) open geodata repository (https://www.ine.gob.cl/herramientas/portal-de-mapas/geodatos-abiertos. CC-BY 4.0 license: https://www.ine.gob.cl/terminos-de-uso-y-licencia-de-datos-abiertos.

    (TIF)

    pgph.0006808.s002.tif (2.6MB, tif)
    S2 Fig. Map of Talca city showing the distribution of vaccine dose clustering in men and its associations with socio-demographic factors (age over 65, educational level, overcrowding, and distance to health center).

    Regional boundaries and road networks were obtained from the Chilean National Statistics Institute (Instituto Nacional de Estadísticas, INE Chile) open geodata repository (https://www.ine.gob.cl/herramientas/portal-de-mapas/geodatos-abiertos. CC-BY 4.0 license: https://www.ine.gob.cl/terminos-de-uso-y-licencia-de-datos-abiertos.

    (TIF)

    pgph.0006808.s003.tif (2.6MB, tif)
    S3 Fig. Map of the La Serena/Coquimbo conurbation showing the distribution of vaccine dose clustering in women and its associations with socio-demographic factors (age over 65, educational level, overcrowding, and distance to health center).

    Regional boundaries and road networks were obtained from the Chilean National Statistics Institute (Instituto Nacional de Estadísticas, INE Chile) open geodata repository (https://www.ine.gob.cl/herramientas/portal-de-mapas/geodatos-abiertos. CC-BY 4.0 license: https://www.ine.gob.cl/terminos-de-uso-y-licencia-de-datos-abiertos.

    (TIF)

    pgph.0006808.s004.tif (2.1MB, tif)
    S4 Fig. Map of La Serena/Coquimbo conurbation showing the distribution of vaccine dose clustering in men and its associations with socio-demographic factors (age over 65, educational level, overcrowding, and distance to health center).

    Regional boundaries and road networks were obtained from the Chilean National Statistics Institute (Instituto Nacional de Estadísticas, INE Chile) open geodata repository (https://www.ine.gob.cl/herramientas/portal-de-mapas/geodatos-abiertos. CC-BY 4.0 license: https://www.ine.gob.cl/terminos-de-uso-y-licencia-de-datos-abiertos.

    (TIF)

    pgph.0006808.s005.tif (2.1MB, tif)
    Attachment

    Submitted filename: Point-by-point response2-2.pdf

    pgph.0006808.s006.pdf (139.5KB, pdf)
    Attachment

    Submitted filename: Point-by-point response.pdf

    pgph.0006808.s007.pdf (869.5KB, pdf)
    Attachment

    Submitted filename: Point-by-point_response_auresp_3.pdf

    pgph.0006808.s008.pdf (210.3KB, pdf)

    Data Availability Statement

    Data Availability Statement: The data for the study can be accessible from https://doi.org/10.5281/zenodo.16365760.


    Articles from PLOS Global Public Health are provided here courtesy of PLOS

    RESOURCES